1. CP-133 Name patient program with siltuximab in multicentric castleman's disease: a case report. (24th March 2015) Authors: Bocchio, F; Bonfichi, M; Calvi, M; Tizzoni, M; Rebagliati, G Journal: European journal of hospital pharmacy Issue: Volume 22(2015)Supplement 1 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DI-079 Brentuximab Vedotin: from Named Patient Program (NPP) to Italian Law 648/96. (24th February 2014) Authors: Rebagliati, G; Bonfichi, M; Zecca, M; Bocchio, F; Gotti, M; Calafiore, L; Cusato, M; Tizzoni, M; Calvi, M Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗